Author

D. Van Looveren

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

H. J. Thibaut· 3 shared T. Vercruysse· 3 shared D. Jochmans· 2 shared D. Schols· 2 shared J. Neyts· 2 shared R. Abdelnabi· 2 shared S. Sharma· 2 shared A. Bruggemans· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

H. J. Thibaut

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BET-independent MLV integration is retargeted in vivo and selects distinct genomic elements for lymphomagenesis

I. Nombela, M. Michiels, D. Van Looveren, L. Marcelis, S. el Ashkar, S. Van Belle, A. Bruggemans, T. Tousseyn, J. Schwaller, F. Christ, R. Gijsbers, J. De Rijck, Z. Debyser

This study compares BET-dependent and -independent MLV integration in mice, finding that BET proteins influence integration site selection but not tumorigenesis.

bioRxiv · Feb 23, 2022 · PreprintMicrobiology

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model

M. Imbrechts, W. Maes, L. Ampofo, N. Van den Berghe, B. Calcoen, D. Van Looveren, S. Noppen, K. Hollevoet, T. Vercruysse, X. Zhang, R. Abdelnabi, C. S.-Y. Foo, H. J. Thibaut, D. Jochmans, K. Ven, , N. Geukens

The paper identifies potent anti-SARS-CoV-2 mAbs that cure infection in hamsters and demonstrates gene-based delivery for in vivo protection against variants.

bioRxiv · Nov 25, 2021Immunology

Updated vaccine protects from infection with SARS-CoV-2 variants, prevents transmission and is immunogenic against Omicron in hamsters

S. Sharma, T. Vercruysse, L. Sanchez-Felipe, W. Kerstens, P. Maes, R. Abdelnabi, C. S. Foo, V. Lemmens, D. Van Looveren, G. Baele, B. Weynand, P. Lemey, J. Neyts, H. J. Thibaut, K. Dallmeier

This study shows an updated vaccine candidate provides full protection against multiple SARS-CoV-2 variants, prevents transmission, and induces neutralizing antibodies against Omicron in hamsters.

bioRxiv · Nov 12, 2021 · PreprintMicrobiology

STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters

R. Boudewijns, H. J. Thibaut, S. J. F. Kaptein, R. Li, V. Vergote, L. Seldeslachts, C. De Keyzer, L. Bervoets, S. Sharma, J. Van Weyenbergh, L. Liesenborghs, J. Ma, S. Jansen, D. Van Looveren, T. Vercruysse, , X. Saelens

This study shows that STAT2 signaling both restricts SARS-CoV-2 spread and causes severe pneumonia in infected hamsters.

bioRxiv · Apr 23, 2020 · PreprintMicrobiology